호흡기 기기 시장 : 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of respiratory devices Market

The global respiratory devices market is witnessing steady growth due to the rising prevalence of chronic respiratory disorders, increasing healthcare awareness, and continuous technological advancements in respiratory care equipment. According to the report, the global respiratory devices market size was valued at USD 26.44 billion in 2025. The market is projected to grow from USD 27.67 billion in 2026 to USD 45.84 billion by 2034, exhibiting a CAGR of 6.51% during the forecast period. In 2025, North America dominated the market with a 40.29% share, supported by a well-established healthcare infrastructure, high diagnosis rates, and the strong presence of leading respiratory device manufacturers.

Respiratory devices are medical equipment designed to assist patients in breathing by delivering oxygen, monitoring respiratory function, or supporting ventilation. These devices are extensively used for the diagnosis and treatment of conditions such as Chronic Obstructive Pulmonary Disease (COPD), asthma, sleep apnea, and other respiratory disorders across hospitals, specialty clinics, and home healthcare settings.

Market Definition and Scope

The respiratory devices market includes a broad range of therapeutic devices, diagnostic & monitoring devices, and consumables & accessories used for respiratory disease management. These products include ventilators, inhalers, nebulizers, Positive Airway Pressure (PAP) devices, spirometers, pulse oximeters, masks, nasal cannulas, and related accessories.

The market serves hospitals, ambulatory surgical centers (ASCs), specialty clinics, home healthcare providers, and other healthcare facilities. Growing demand for portable, AI-enabled, and home-use respiratory devices is expanding the application scope of these products across developed and emerging healthcare markets.

Market Dynamics

Drivers

The increasing prevalence of respiratory diseases such as COPD, asthma, sleep apnea, and infectious respiratory illnesses is the primary driver of market growth. Rising air pollution, smoking habits, aging populations, and changing lifestyles have significantly increased the number of patients requiring respiratory diagnosis and treatment. In addition, continuous improvements in healthcare infrastructure across emerging economies and growing awareness regarding early disease diagnosis are supporting market expansion.

Trends

A major trend shaping the market is the growing adoption of technologically advanced respiratory devices. Manufacturers are introducing smart inhalers, portable ventilators, wearable respiratory monitoring systems, and AI-enabled diagnostic solutions to improve treatment outcomes and patient adherence. Integration of artificial intelligence and remote monitoring technologies is enabling more accurate diagnosis and real-time patient management, particularly for chronic respiratory diseases.

Restraints

One of the major challenges limiting market growth is the shortage of skilled respiratory therapists and trained healthcare professionals, particularly in developing countries. In addition, limited patient adherence to long-term respiratory therapies and the high cost of advanced respiratory equipment continue to restrict product adoption in price-sensitive markets.

Impact of COVID-19

The COVID-19 pandemic had a positive impact on the respiratory devices market as the unprecedented increase in respiratory complications significantly boosted demand for ventilators, oxygen therapy equipment, pulse oximeters, masks, and respiratory monitoring devices. Increased production capacity and government investments in healthcare infrastructure further accelerated market growth during and after the pandemic.

Segmentation Analysis

By type, the therapeutic devices segment dominates the market and is expected to account for 70.64% of the global market in 2026. Growing demand for ventilators, PAP devices, inhalers, and nebulizers, along with continuous product innovation, continues to drive segment growth. Diagnostic & monitoring devices represent the second-largest segment due to increasing respiratory disease screening and monitoring.

By application, the sleep apnea segment is projected to lead the market with a 32.37% share in 2026, supported by the rising prevalence of obstructive sleep apnea and increasing adoption of advanced PAP therapy devices. COPD and asthma remain significant application areas due to the growing global burden of chronic respiratory diseases.

By end-user, home care settings are expected to dominate the market with a 43.54% share in 2026, driven by increasing demand for portable respiratory devices, remote patient monitoring, and home-based treatment solutions. Hospitals & ASCs continue to represent an important end-user segment owing to high patient admissions and critical care requirements.

Regional Insights

North America dominated the global respiratory devices market with a value of USD 10.65 billion in 2025 and is projected to reach USD 11.17 billion in 2026. The region benefits from advanced healthcare infrastructure, widespread adoption of innovative respiratory technologies, and a high prevalence of respiratory disorders. The U.S. market is projected to reach USD 10.38 billion by 2026.

Europe accounted for USD 8.68 billion in 2025 and is expected to reach USD 9.04 billion in 2026, supported by increasing cases of COPD and asthma, favorable reimbursement policies, and continuous healthcare investments.

Asia Pacific generated USD 4.46 billion in 2025 and is projected to reach USD 4.70 billion in 2026. Rising geriatric populations, expanding healthcare infrastructure, and increasing respiratory disease awareness continue to support regional growth. China, Japan, and India remain major contributors to market expansion.

Latin America and the Middle East & Africa are witnessing gradual growth due to improving healthcare access, increasing disease awareness, and government initiatives aimed at strengthening respiratory care services.

Competitive Landscape

The global respiratory devices market is highly competitive, with leading companies focusing on technological innovation, product launches, partnerships, and geographical expansion. Major players include Koninklijke Philips N.V., Medtronic, ResMed, Inc., Fisher & Paykel Healthcare Limited, Masimo, Getinge AB, GE HealthCare, and Baxter. These companies continue to invest in smart respiratory technologies, portable devices, AI-enabled monitoring systems, and advanced ventilation solutions to strengthen their market position.

Report Coverage

This report provides a comprehensive analysis of the global respiratory devices market, including market size for 2025, 2026, and 2034, key growth drivers, market trends, restraints, COVID-19 impact, segmentation by type, application, and end-user, regional analysis, competitive landscape, and recent industry developments. The report also highlights technological advancements and strategic initiatives adopted by major market participants.

Conclusion

The global respiratory devices market is expected to witness steady long-term growth, expanding from USD 26.44 billion in 2025 to USD 45.84 billion by 2034. Rising respiratory disease prevalence, increasing adoption of home healthcare, rapid technological innovation, and growing investments in healthcare infrastructure will continue to drive market expansion. As demand for smart, portable, and AI-enabled respiratory solutions increases, manufacturers focusing on innovation, accessibility, and patient-centric care are expected to strengthen their competitive position throughout the forecast period.

Segmentation By Type

• Therapeutic Devices
  • Positive Airway Pressure (PAP) Devices
  • Airway Management Devices
  • Ventilators
  • Inhalers
  • Nebulizers
  • Others
• Diagnostic & Monitoring Devices
  • Spirometers
  • Polysomnography Devices
  • Pulse Oximeters
  • Others
• Consumables and Accessories
  • Masks
  • Nasal Cannula
  • Others

By Application

• Chronic Obstructive Pulmonary Disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Others

By End-User

• Hospitals and ASCs
• Specialty Clinics
• Home Care Settings
• Others

By Region

• North America (By Type, Application, End-User, and Country)
  • U.S.
  • Canada
• Europe (By Type, Application, End-User, and Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Type, Application, End-User, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Type, Application, End-User, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, Application, End-User, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Respiratory Disorders, Key Countries/Region, 2025
• 4.2. Technological Advancements in Respiratory Devices
• 4.3. New Product Launches
• 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships
• 4.5. Impact of COVID-19 on Global Respiratory Devices Market

5. Global Respiratory Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Therapeutic Devices
    • 5.1.1.1. Positive Airway Pressure (PAP) Devices
    • 5.1.1.2. Airway Management Devices
    • 5.1.1.3. Ventilators
    • 5.1.1.4. Inhalers
    • 5.1.1.5. Nebulizers
    • 5.1.1.6. Others
  • 5.1.2. Diagnostic & Monitoring Devices
    • 5.1.2.1. Spirometers
    • 5.1.2.2. Polysomnography Devices
    • 5.1.2.3. Pulse Oximeters
    • 5.1.2.4. Others
  • 5.1.3. Consumables and Accessories
    • 5.1.3.1. Masks
    • 5.1.3.2. Nasal Cannula
    • 5.1.3.3. Others
  • 5.1.4. Market Analysis, Insights and Forecast - By Application
    • 5.1.4.1. Chronic Obstructive Pulmonary Disease (COPD)
    • 5.1.4.2. Sleep Apnea
    • 5.1.4.3. Asthma
    • 5.1.4.4. Infectious Diseases
    • 5.1.4.5. Others
  • 5.1.5. Market Analysis, Insights and Forecast - By End User
    • 5.1.5.1. Hospitals and ASCs
    • 5.1.5.2. Specialty Clinics
    • 5.1.5.3. Home Care Settings
    • 5.1.5.4. Others
• 5.2. Market Analysis, Insights and Forecast - By Region
  • 5.2.1. North America
  • 5.2.2. Europe
  • 5.2.3. Asia Pacific
  • 5.2.4. Latin America
  • 5.2.5. Middle East & Africa

6. North America Respiratory Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Therapeutic Devices
    • 6.1.1.1. Positive Airway Pressure (PAP) Devices
    • 6.1.1.2. Airway Management Devices
    • 6.1.1.3. Ventilators
    • 6.1.1.4. Inhalers
    • 6.1.1.5. Nebulizers
    • 6.1.1.6. Others
  • 6.1.2. Diagnostic & Monitoring Devices
    • 6.1.2.1. Spirometers
    • 6.1.2.2. Polysomnography Devices
    • 6.1.2.3. Pulse Oximeters
    • 6.1.2.4. Others
  • 6.1.3. Consumables and Accessories
    • 6.1.3.1. Masks
    • 6.1.3.2. Nasal Cannula
    • 6.1.3.3. Others
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Chronic Obstructive Pulmonary Disease (COPD)
  • 6.2.2. Sleep Apnea
  • 6.2.3. Asthma
  • 6.2.4. Infectious Diseases
  • 6.2.5. Others
• 6.3. Market Analysis, Insights and Forecast - By End User
  • 6.3.1. Hospitals and ASCs
  • 6.3.2. Specialty Clinics
  • 6.3.3. Home Care Settings
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Respiratory Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Therapeutic Devices
    • 7.1.1.1. Positive Airway Pressure (PAP) Devices
    • 7.1.1.2. Airway Management Devices
    • 7.1.1.3. Ventilators
    • 7.1.1.4. Inhalers
    • 7.1.1.5. Nebulizers
    • 7.1.1.6. Others
  • 7.1.2. Diagnostic & Monitoring Devices
    • 7.1.2.1. Spirometers
    • 7.1.2.2. Polysomnography Devices
    • 7.1.2.3. Pulse Oximeters
    • 7.1.2.4. Others
  • 7.1.3. Consumables and Accessories
    • 7.1.3.1. Masks
    • 7.1.3.2. Nasal Cannula
    • 7.1.3.3. Others
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Chronic Obstructive Pulmonary Disease (COPD)
  • 7.2.2. Sleep Apnea
  • 7.2.3. Asthma
  • 7.2.4. Infectious Diseases
  • 7.2.5. Others
• 7.3. Market Analysis, Insights and Forecast - By End User
  • 7.3.1. Hospitals and ASCs
  • 7.3.2. Specialty Clinics
  • 7.3.3. Home Care Settings
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.4.1. France
  • 7.4.2. Italy
  • 7.4.3. Spain
  • 7.4.4. U.K.
  • 7.4.5. Germany
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Respiratory Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Therapeutic Devices
    • 8.1.1.1. Positive Airway Pressure (PAP) Devices
    • 8.1.1.2. Airway Management Devices
    • 8.1.1.3. Ventilators
    • 8.1.1.4. Inhalers
    • 8.1.1.5. Nebulizers
    • 8.1.1.6. Others
  • 8.1.2. Diagnostic & Monitoring Devices
    • 8.1.2.1. Spirometers
    • 8.1.2.2. Polysomnography Devices
    • 8.1.2.3. Pulse Oximeters
    • 8.1.2.4. Others
  • 8.1.3. Consumables and Accessories
    • 8.1.3.1. Masks
    • 8.1.3.2. Nasal Cannula
    • 8.1.3.3. Others
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Chronic Obstructive Pulmonary Disease (COPD)
  • 8.2.2. Sleep Apnea
  • 8.2.3. Asthma
  • 8.2.4. Infectious Diseases
  • 8.2.5. Others
• 8.3. Market Analysis, Insights and Forecast - By End User
  • 8.3.1. Hospitals and ASCs
  • 8.3.2. Specialty Clinics
  • 8.3.3. Home Care Settings
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.4.1. China
  • 8.4.2. Japan
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Respiratory Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Therapeutic Devices
    • 9.1.1.1. Positive Airway Pressure (PAP) Devices
    • 9.1.1.2. Airway Management Devices
    • 9.1.1.3. Ventilators
    • 9.1.1.4. Inhalers
    • 9.1.1.5. Nebulizers
    • 9.1.1.6. Others
  • 9.1.2. Diagnostic & Monitoring Devices
    • 9.1.2.1. Spirometers
    • 9.1.2.2. Polysomnography Devices
    • 9.1.2.3. Pulse Oximeters
    • 9.1.2.4. Others
  • 9.1.3. Consumables and Accessories
    • 9.1.3.1. Masks
    • 9.1.3.2. Nasal Cannula
    • 9.1.3.3. Others
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Chronic Obstructive Pulmonary Disease (COPD)
  • 9.2.2. Sleep Apnea
  • 9.2.3. Asthma
  • 9.2.4. Infectious Diseases
  • 9.2.5. Others
• 9.3. Market Analysis, Insights and Forecast - By End User
  • 9.3.1. Hospitals and ASCs
  • 9.3.2. Specialty Clinics
  • 9.3.3. Home Care Settings
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Respiratory Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Therapeutic Devices
    • 10.1.1.1. Positive Airway Pressure (PAP) Devices
    • 10.1.1.2. Airway Management Devices
    • 10.1.1.3. Ventilators
    • 10.1.1.4. Inhalers
    • 10.1.1.5. Nebulizers
    • 10.1.1.6. Others
  • 10.1.2. Diagnostic & Monitoring Devices
    • 10.1.2.1. Spirometers
    • 10.1.2.2. Polysomnography Devices
    • 10.1.2.3. Pulse Oximeters
    • 10.1.2.4. Others
  • 10.1.3. Consumables and Accessories
    • 10.1.3.1. Masks
    • 10.1.3.2. Nasal Cannula
    • 10.1.3.3. Others
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Chronic Obstructive Pulmonary Disease (COPD)
  • 10.2.2. Sleep Apnea
  • 10.2.3. Asthma
  • 10.2.4. Infectious Diseases
  • 10.2.5. Others
• 10.3. Market Analysis, Insights and Forecast - By End User
  • 10.3.1. Hospitals and ASCs
  • 10.3.2. Specialty Clinics
  • 10.3.3. Home Care Settings
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Koninklijke Philips N.V.
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Medtronic
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. ResMed, Inc.
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Fisher & Paykel Healthcare Limited
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Masimo
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Getinge AG
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. GE Healthcare
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Baxter
    • 11.2.8.1. Overview
    • 11.2.8.2. Products
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)